Normal Visceral Fat Levels: UK Guide

Normal visceral fat levels are an important marker of metabolic health, yet many people are unaware of how much they carry or what the thresholds mean. Visceral fat is stored deep within the abdominal cavity, surrounding vital organs, and poses a greater health risk than the fat visible beneath the skin. Unlike overall body weight or BMI, visceral fat is closely linked to insulin resistance, cardiovascular disease and type 2 diabetes. This article explains what a healthy visceral fat level looks like, how it is measured in UK clinical practice, what drives it upwards, and the evidence-based steps you can take to reduce it.

What is visceral fat and why does it matter for your health?

Visceral fat is metabolically active fat stored around internal organs that raises the risk of type 2 diabetes, cardiovascular disease and metabolic syndrome through insulin resistance and systemic inflammation, independently of overall body weight.

Visceral fat is the metabolically active fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it poses a greater health risk than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at the waist, visceral fat is not visible from the outside, which means a person can carry a harmful amount of it while appearing to have a relatively normal body shape or weight.

The reason visceral fat is considered particularly concerning is its proximity to vital organs and its biological activity. It is associated with the release of fatty acids, inflammatory markers and hormones into the portal circulation, which feeds the liver. This is linked to insulin resistance, raised blood glucose, elevated triglycerides and lower levels of HDL (good) cholesterol, all of which contribute to an increased risk of type 2 diabetes, cardiovascular disease and metabolic-associated steatotic liver disease (sometimes still referred to as non-alcoholic fatty liver disease or NAFLD on older NHS resources).^[3][4]

Evidence consistently shows that high visceral fat is associated with systemic low-grade inflammation, which plays a role in a wide range of chronic conditions including hypertension, certain cancers and metabolic syndrome. Importantly, this risk exists independently of overall body weight. A person with a BMI in the healthy range can still carry excess visceral fat, a pattern sometimes described as having a normal-weight obesity phenotype.

Because visceral fat cannot be measured directly without specialist imaging, clinicians use waist circumference and waist-to-height ratio as practical proxy measures. The NHS highlights waist circumference as a useful indicator of abdominal fat and associated health risk, making it a straightforward tool for both patients and healthcare professionals.^[5][7]

What is a normal visceral fat level for adults in the UK?

NHS and NICE guidance identifies increased risk at waist circumferences of 94 cm or above in men and 80 cm or above in women (white European populations), with a waist-to-height ratio below 0.5 considered healthy.

There is no single clinical measurement called a "visceral fat level". In practice, clinicians use waist circumference and waist-to-height ratio as validated proxies, because direct measurement of visceral fat requires MRI or CT scanning, which are not routinely available outside research or specialist settings.

For waist circumference, NHS and NICE guidance identifies increased cardiometabolic risk at 94 cm (37 inches) or above in men and 80 cm (31.5 inches) or above in women (for white European populations). High risk is indicated at 102 cm (40 inches) or above in men and 88 cm (34.5 inches) or above in women. To measure correctly, find the midpoint between the lower rib and the top of the hip bone, wrap a tape measure around the bare skin at that point, and take the reading after a gentle exhalation without pulling the tape tight.

Waist-to-height ratio is an additional proxy endorsed in some UK guidance: a ratio below 0.5 (that is, your waist circumference is less than half your height) is generally considered within a healthy range for adults.^[6][7]

Ethnicity influences risk at any given waist circumference. WHO and IDF recommendations, reflected in NICE guidance, acknowledge that people of South Asian, Chinese, Japanese and other Asian backgrounds carry a higher cardiometabolic risk at lower waist circumferences than white European populations. For these groups, lower action thresholds are often applied in clinical practice, with some guidelines using around 90 cm in men and 80 cm in women, though exact cut-offs vary by source and subgroup.

Some consumer body composition scales assign a visceral fat rating, typically on a scale of 1 to 59, using bioelectrical impedance analysis. These ratings are device-specific, vary between manufacturers, and are not validated against the clinical thresholds used by NHS clinicians. They can also be affected by hydration status, recent exercise and the time of day, so they should be interpreted with considerable caution and are not a substitute for a clinical assessment.

If you are concerned about your visceral fat, your GP can assess your waist circumference, calculate your waist-to-height ratio and consider these alongside your BMI, blood pressure and blood test results to give a fuller picture of your metabolic health.

What causes visceral fat to rise above a healthy level?

Visceral fat rises due to excess calorie intake, physical inactivity, chronic stress, poor sleep, hormonal changes such as menopause, alcohol consumption, certain medicines and conditions including Cushing's syndrome and PCOS.

Visceral fat accumulates when energy intake consistently exceeds energy expenditure over time, but several biological, hormonal and lifestyle factors influence where in the body excess fat is preferentially stored. A diet high in ultra-processed foods, refined carbohydrates and added sugars is associated with visceral fat gain, partly because these dietary patterns are linked to insulin resistance and abdominal fat deposition.

Physical inactivity is one of the most significant modifiable contributors. Sedentary behaviour is associated with impaired insulin sensitivity and greater visceral fat accumulation. Evidence also suggests that prolonged sitting throughout the day may have an adverse effect on abdominal fat distribution independently of overall activity levels, though the precise mechanisms are still being studied.

Hormonal changes play a substantial role. Cortisol, the primary stress hormone, is associated with visceral fat deposition when chronically elevated, which is why persistent psychological stress and poor sleep are recognised risk factors.^[10][11] In women, the decline in oestrogen during the menopause transition is associated with a shift in fat distribution from the hips and thighs towards the abdomen, increasing visceral fat even without significant weight gain.^[13][14] In men, declining testosterone levels with age are associated with a similar pattern.

Genetics also influence individual susceptibility, meaning two people with identical diets and activity levels may accumulate visceral fat at different rates. Alcohol consumption, particularly heavy or regular drinking, is an additional contributor, as alcohol metabolism in the liver is associated with hepatic and visceral fat accumulation. Certain medicines, including long-term corticosteroids and some antipsychotics, may contribute to central fat gain as a recognised side effect; the BNF and individual medicine information provide further detail.^[16][17]

Some medical conditions, including Cushing's syndrome, hypothyroidism and polycystic ovary syndrome (PCOS), can also promote central adiposity.^[18] If you suspect an underlying medical cause, speak to your GP for assessment.

How can you reduce visceral fat through diet and lifestyle changes?

A Mediterranean-style diet, at least 150 minutes of moderate aerobic activity per week combined with resistance training, and improved sleep are the most evidence-based approaches to reducing visceral fat.

Visceral fat tends to respond well to lifestyle intervention, and evidence suggests it may be more responsive to diet and exercise than subcutaneous fat, though the degree and speed of reduction varies between individuals. A sustained calorie deficit achieved through a balanced, whole-food diet is the cornerstone of visceral fat reduction, with particular benefit associated with reducing ultra-processed foods, refined sugars and excess alcohol.

In terms of dietary patterns, a Mediterranean-style diet, rich in vegetables, legumes, wholegrains, oily fish, nuts and olive oil, has evidence supporting reductions in visceral fat and improvements in cardiometabolic markers.^[19][20] Reducing intake of sugar-sweetened drinks and foods with a high glycaemic load is associated with improved abdominal fat distribution, likely through effects on insulin and energy balance. Adequate dietary protein also supports fat loss by helping to preserve lean muscle mass during a calorie deficit.

Physical activity is equally important. Both aerobic exercise (such as brisk walking, cycling or swimming) and resistance training are associated with reductions in visceral fat, and combining the two produces greater benefit than either alone.^[23][24] UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults, alongside muscle-strengthening activities on two or more days.^[26][27] Even modest increases in daily movement, such as breaking up prolonged sitting, contribute to improvement.

Sleep and stress management are often overlooked but are clinically relevant. NHS guidance suggests most adults need between 6 and 9 hours of sleep per night.^[29][30] Evidence-based approaches to stress reduction, such as mindfulness or cognitive behavioural techniques, can support improvements in sleep, health behaviours and overall wellbeing, which in turn may help reduce visceral fat accumulation over time.

If your waist circumference or waist-to-height ratio is above the thresholds described above, or if you have symptoms that may suggest type 2 diabetes or another metabolic condition, it is worth speaking to your GP. They can arrange relevant investigations, including HbA1c, fasting glucose, lipid profile and blood pressure measurement, and refer you to structured weight management services if appropriate. In some cases, a prescriber may consider pharmacological options as part of a broader management plan. Bolt Pharmacy is a GPhC-registered online pharmacy (GPhC regulates pharmacies in Great Britain; PSNI covers Northern Ireland) offering online weight-management consultations with prescriber review and pharmacist support, where clinically appropriate options may be discussed.

Scientific References

1. A causative link between visceral adiposity and hepatic insulin resistance (portal hypothesis).
2. Insulin resistance in type 2 diabetes: role of fatty acids.
3. Non-alcoholic fatty liver disease (NAFLD).
4. Selective SGLT2 inhibitors in MASLD/MASH: an outcome-specific systematic review and meta-analysis.
5. Overweight and obesity in adults.
6. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
7. Calculate your waist to height ratio.
8. Keep the size of your waist to less than half of your height – NICE recommends.
9. NICE waist-to-height ratio guidelines: suitability for classifying children at risk.
10. Cortisol: the villain in metabolic syndrome?.
11. Psychological and metabolic stress: a recipe for accelerated cellular aging?.
12. Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia.
13. Perimenopause and metabolic vulnerability: hormones, body composition and lifestyle changes.
14. Elevated adipose differentiation-related protein level in ovariectomized mice correlates with tissue-specific regulation of estrogen.
15. Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women.
16. Psychoses and related disorders – Treatment summaries (BNF).
17. Obesity – Treatment summaries (BNF).
18. Cushing's syndrome.
19. Effects of the Mediterranean Diet on the Components of Metabolic Syndrome.
20. Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health (Circulation).
21. The effects of Mediterranean diet with and without exercise on body composition in adults with chronic disease.
22. Effect of Predominantly Plant-Based Diets on Visceral Fat: A Systematic Review and Meta-Analysis.
23. Impact of Different Exercise Modalities on Visceral Adipose Tissue in Normal Weight and Low-Overweight Individuals.
24. Effects of concurrent training on fat mass and its distribution in individuals with overweight or obesity.
25. Comparative Efficacy of Exercise Type on Visceral Adipose Tissue in Patients With Prediabetes and Type 2 Diabetes Mellitus.
26. Physical activity guidelines: UK Chief Medical Officers' report.
27. UK Chief Medical Officers' physical activity guidelines (full guidance).
28. Physical activity guidelines for adults aged 19 to 64.
29. Sleep problems – Every Mind Matters.
30. Insomnia.
31. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
32. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

Frequently Asked Questions